The Moving Average Convergence Divergence (MACD) for NRC turned positive on September 06, 2023. Looking at past instances where NRC's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on September 06, 2023. You may want to consider a long position or call options on NRC as a result. In of 109 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
NRC moved above its 50-day moving average on September 07, 2023 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for NRC crossed bullishly above the 50-day moving average on September 12, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NRC advanced for three days, in of 311 cases, the price rose further within the following month. The odds of a continued upward trend are .
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
NRC broke above its upper Bollinger Band on September 07, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for NRC entered a downward trend on September 07, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NRC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock slightly better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.728) is normal, around the industry mean (21.026). P/E Ratio (39.526) is within average values for comparable stocks, (152.571). Projected Growth (PEG Ratio) (1.323) is also within normal values, averaging (2.632). Dividend Yield (0.013) settles around the average of (0.088) among similar stocks. P/S Ratio (7.770) is also within normal values, averaging (74.029).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of market research services for the healthcare industry
A.I.dvisor indicates that over the last year, NRC has been loosely correlated with CPSI. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if NRC jumps, then CPSI could also see price increases.